UVRI-IAVI HIV Vaccine Program LTD. CRS

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• HIV2 trials
• Tuberculosis1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• COVID-19 Prevention Network2 trials
• National Institute of Allergy and Infectious Diseases (NIAID)1 trial

Running trials

• Active, not recruiting

  Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women

  NCT03164564· Phase 3· National Institute of Allergy and Infectious Diseases (NIAID)· Source

Closed trials

• Completed

  Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008

  NCT06585683· COVID-19 Prevention Network· Source

• Completed

  Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern

  NCT05168813· Phase 2/3· COVID-19 Prevention Network· Source